Skip to Content

Amphetamine Mixed Salts, Immediate-Release Tablets

Last Updated: March 23, 2015
Status: Resolved

Products Affected - Description

Amphetamine mixed salts immediate-release tablets

Reason for the Shortage

Teva had product on allocation due to DEA quotas that are projected annually.

Available Products

Amphetamine mixed salts immediate-release tablets, Sandoz
5 mg tablets, 100 count (NDC 00185-0084-01)
10 mg tablets, 100 count (NDC 00185-0111-01)
20 mg tablets, 100 count (NDC 00185-0401-01)
30 mg tablets, 100 count (NDC 00185-0404-01)

 
Amphetamine mixed salts immediate-release tablets, Teva
5 mg tablets, 100 count (NDC 00555-0971-02)
7.5 mg tablets, 100 count (NDC 00555-0775-02)
12.5 mg tablets, 100 count (NDC 00555-0776-02)
15 mg tablets, 100 count (NDC 00555-0777-02)
10 mg tablets, 100 count (NDC 00555-0972-02)
20 mg tablets, 100 count (NDC 00555-0973-02)
30 mg tablets, 100 count (NDC 00555-0974-02)
 
Amphetamine mixed salts immediate-release tablets, CorePharma
5 mg tablets, 100 count (NDC 64720-0130-10)
10 mg tablets, 100 count (NDC 64720-0132-10)
20 mg tablets, 100 count (NDC 64720-0135-10)
30 mg tablets, 100 count (NDC 64720-0136-10)
 
Adderall, Teva
5 mg tablets, 100 count (NDC 00555-0762-02)
7.5 mg tablets, 100 count (NDC 00555-0763-02)
10 mg tablets, 100 count (NDC 57844-0110-01)
12.5 mg tablets, 100 count (NDC 57844-0112-01)
15 mg tablets, 100 count (NDC 57844-0115-01)
20 mg tablets, 100 count (NDC 57844-0120-01)
30 mg tablets, 100 count (NDC 57844-0130-01)

Estimated Resupply Dates

All presentations are available.

Updated

March 23, February 4, 2015; December 2, October 22, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide